Get All Access for $5/mo

Biocon Net Profit of Up By 550% to INR 660 Crore for Q1FY25 Biocon generated a total revenue of INR 4,567 crore in Q1FY25 and witnessed a net profit of 550 per cent

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Freepik

Biocon reported a total consolidated revenue of INR 4,567 crore for Q1FY25, a 30 per cent year-on-year (YoY) increase from the same period previous year. Other income includes proceeds of INR 1,057 crore on account of the strategic collaboration between Biocon Biologics and Eris Lifesciences. The biopharmaceuticals company, in a regulatory filing, reported an EBITDA for the quarter of INR 1,755 crore, representing an EBITDA margin of 38 per cent. Net R&D investments for the quarter stood at INR 228 crore, representing 9 per cent of revenue ex-Syngene.

The outlook for this fiscal remains positive, as the company anticipates stronger growth in H2FY25, with new product launches in the Biosimilars and Generics businesses, including Liraglutide for diabetes and obesity in the UK and other markets. Additionally, Biocon expect improved business prospects for Syngene, supported by a resurgent biotech funding environment in the U.S.

"Biocon has reported consolidated revenues of INR 4,567 crore for Q1FY25, delivering a strong 30 per cent YoY growth, with EBITDA growing 117 per cent to INR 1,755 crore and a net profit of INR 660 crore. This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences. Post integration, the Biosimilars business has delivered a healthy performance with 11 per cent like- for- like growth, as it consolidates business across global markets. This has helped offset the challenges of pricing pressures in the Generics segment and the difficult U.S. Biotech funding environment, which has impacted the growth trajectory of our Research Services business," said Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics.

The company's profit before tax and exceptional items stood at INR 1,114 crore with a reported net profit for the quarter reaching INR 660 crore, a 551 per cent jump from Q1FY24.

Entrepreneur Staff

Entrepreneur Staff

Editor

For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Side Hustle

The Side Hustle She Started in a High School Locker Room Hit Multimillion-Dollar Revenue — and Taylor Swift Is a Fan: 'Invest in Yourself'

Elena Bonvicini, now 25, was inspired to start her side hustle during a 2016 visit to her grandparents in Wisconsin.

Employee Experience & Recruiting

Free Webinar | October 10: Best Practice Strategies for Seasonal Staffing

Is your business prepared to capitalize on a busy holiday season? In our upcoming webinar, Scott Greenberg, award-winning franchise owner, will share his expertise on how to effectively recruit, onboard, and retain seasonal staff. Register now!

Business News

Mark Zuckerberg Uses an Easy But Powerful Formula to Keep Facebook Relevant — Here's How It Works

Zuckerberg says Meta never thought small, even in the early days when it was just Facebook.

Growing a Business

6 Ways Automation Can Eliminate Your Company's Compliance Risks

Leverage automated systems to track, monitor and complete regulatory and compliance tasks.

Starting a Business

Crack the Chicken-and-Egg Dilemma — How Startups Can Thrive Against the Odds

Focus on one side of your marketplace first, build value for sellers or buyers and the other side will follow.